Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Eyelid inflammation treatment trial halted midway

NCT ID NCT06400511

First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tested a medicated ointment (pimecrolimus) for blepharitis, a condition causing red, flaky, and uncomfortable eyelids. The trial enrolled 477 people aged 2 and older with a history of blepharitis. The goal was to see if the ointment could clear eyelid debris and reduce discomfort, but the study was terminated early.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLEPHARITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Clinical Investigative Site

    Pheonix, Arizona, 85032, United States

  • Clinical Investigator Site

    Garden Grove, California, 92843, United States

  • Clinical Investigator Site

    Glendale, California, 91204, United States

  • Clinical Investigator Site

    Inglewood, California, 90301, United States

  • Clinical Investigator Site

    Newport Beach, California, 92663, United States

  • Clinical Investigator Site

    Petaluma, California, 94954, United States

  • Clinical Investigator Site

    Rancho Cordova, California, 95670, United States

  • Clinical Investigator Site

    Aurora, Colorado, 80045, United States

  • Clinical Investigator Site

    Crystal River, Florida, 34429, United States

  • Clinical Investigator Site

    Largo, Florida, 33773, United States

  • Clinical Investigator Site

    Tampa, Florida, 33603, United States

  • Clinical Investigator Site

    Atlanta, Georgia, 30339, United States

  • Clinical Investigator Site

    Morrow, Georgia, 30260, United States

  • Clinical Investigator Site

    Pittsburg, Kansas, 66762, United States

  • Clinical Investigator Site

    Louisville, Kentucky, 40206, United States

  • Clinical Investigator Site

    Havre de Grace, Maryland, 21078, United States

  • Clinical Investigator Site

    Medina, Minnesota, 55340, United States

  • Clinical Investigator Site

    Kansas City, Missouri, 64154, United States

  • Clinical Investigator Site

    Washington, Missouri, 63090, United States

  • Clinical Investigator Site

    Garner, North Carolina, 27529, United States

  • Clinical Investigator Site

    Cincinnati, Ohio, 45242, United States

  • Clinical Investigator Site

    Cranberry Township, Pennsylvania, 16066, United States

  • Clinical Investigator Site

    Smyrna, Tennessee, 37167, United States

  • Clinical Investigator Site

    Austin, Texas, 78731, United States

  • Clinical Investigator Site

    Lakeway, Texas, 78738, United States

  • Clinical Investigator Site

    San Antonio, Texas, 78229, United States

  • Clinical Investigator Site

    Clinton, Utah, 84015, United States

  • Clinical Investigator Site

    Lynchburg, Virginia, 24502, United States

  • Investigative Site

    St Louis, Missouri, 63131, United States

Conditions

Explore the condition pages connected to this study.